# Study on the Antibody Level Against SARS-CoV-2 （COVID-19）in Dazhu County in 2023

> **NCT05758675** · — · UNKNOWN · sponsor: **Sinocelltech Ltd.** · enrollment: 20000 (estimated)

## Conditions studied

- COVID-19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05758675
- **Lead sponsor:** Sinocelltech Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-21
- **Primary completion:** 2023-09-08
- **Final completion:** 2023-12-08
- **Target enrollment:** 20000 (ESTIMATED)
- **Last updated:** 2023-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05758675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05758675, "Study on the Antibody Level Against SARS-CoV-2 （COVID-19）in Dazhu County in 2023". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05758675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*